Meditera Tibbi Malzeme Sanayi ve Ticaret Anonim Sirketi Past Earnings Performance
Past criteria checks 2/6
Meditera Tibbi Malzeme Sanayi ve Ticaret Anonim Sirketi's earnings have been declining at an average annual rate of -22.4%, while the Medical Equipment industry saw earnings growing at 8.1% annually. Revenues have been growing at an average rate of 38.5% per year. Meditera Tibbi Malzeme Sanayi ve Ticaret Anonim Sirketi's return on equity is 6.2%, and it has net margins of 9.1%.
Key information
-22.4%
Earnings growth rate
-29.5%
EPS growth rate
| Medical Equipment Industry Growth | 12.3% |
| Revenue growth rate | 38.5% |
| Return on equity | 6.2% |
| Net Margin | 9.1% |
| Last Earnings Update | 30 Sep 2024 |
Recent past performance updates
Recent updates
Revenue & Expenses Breakdown
How Meditera Tibbi Malzeme Sanayi ve Ticaret Anonim Sirketi makes and spends money. Based on latest reported earnings, on an LTM basis.
Earnings and Revenue History
| Date | Revenue | Earnings | G+A Expenses | R&D Expenses |
|---|---|---|---|---|
| 30 Sep 24 | 1,407 | 129 | 318 | 15 |
| 30 Jun 24 | 1,393 | -16 | 307 | 14 |
| 31 Mar 24 | 1,504 | 93 | 295 | 14 |
| 31 Dec 23 | 1,452 | 26 | 288 | 14 |
| 30 Sep 23 | 2,511 | -166 | 452 | 16 |
| 30 Jun 23 | 2,191 | 34 | 382 | 14 |
| 31 Mar 23 | 1,848 | -11 | 311 | 11 |
| 31 Dec 22 | 1,596 | 114 | 242 | 7 |
| 30 Sep 22 | 731 | 359 | 107 | 5 |
| 30 Jun 22 | 607 | 304 | 91 | 3 |
| 31 Mar 22 | 471 | 226 | 76 | 3 |
| 31 Dec 21 | 376 | 168 | 67 | 2 |
| 30 Sep 21 | 364 | 59 | 66 | 0 |
| 30 Jun 21 | 370 | 68 | 67 | 1 |
| 31 Mar 21 | 362 | 62 | 66 | 0 |
| 31 Dec 20 | 359 | 60 | 64 | 1 |
Quality Earnings: MEDTR has high quality earnings.
Growing Profit Margin: MEDTR became profitable in the past.
Free Cash Flow vs Earnings Analysis
Past Earnings Growth Analysis
Earnings Trend: MEDTR's earnings have declined by 22.4% per year over the past 5 years.
Accelerating Growth: MEDTR has become profitable in the last year, making the earnings growth rate difficult to compare to its 5-year average.
Earnings vs Industry: MEDTR has become profitable in the last year, making it difficult to compare its past year earnings growth to the Medical Equipment industry (-1.1%).
Return on Equity
High ROE: MEDTR's Return on Equity (6.2%) is considered low.